Filtered By:
Infectious Disease: Outbreaks
This page shows you your search results in order of relevance. This is page number 19.
Order by Relevance | Date
Total 348 results found since Jan 2013.
Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes —A multicenter registry
by Alexander Fardman, Doron Zahger, Katia Orvin, Daniel Oren, Natalia Kofman, Jameel Mohsen, Or Tsafrir, Elad Asher, Ronen Rubinshtein, Jafari Jamal, Roi Efraim, Majdi Halabi, Yacov Shacham, Lior Henri Fortis, Tal Cohen, Robert Klempfner, Amit Segev, Roy Beigel, Shlomi Matetzky
BackgroundWe aimed to describe the characteristics and in-hospital outcomes of ST-segment elevation myocardial infarction (STEMI) patients during the Covid-19 era. MethodsWe conducted a prospective, multicenter study involving 13 intensive cardiac care units, to evaluate consecutive STEMI patients admitted throughout an 8-week period during the Covi...
Source: PLoS One - June 18, 2021 Category: Biomedical Science Authors: Alexander Fardman Source Type: research
Reduction in Neurological Disease Hospitalization Rate During Covid-19 Pandemic in Abruzzo
ConclusionsDespite the severity of the diseases included in MDC 1 (i.e. ischemic stroke, intracranial hemorrhage), a significant decline was detected in hospital admissions in Abruzzo. Subsequently, a high number of subjects might have not received the necessary health assistance leading to an increase in mortality and morbidity for these severe pathologies. Additionally, patients might have avoided seeking hospital care in response to the fear of contagion triggered either by media or as a result of the stay-at-home government recommendations.Key messagesAn alarming reduction in all types of hospitalizations for neurologi...
Source: The European Journal of Public Health - October 20, 2021 Category: General Medicine Source Type: research
Effects of an Infection Control Protocol for Coronavirus Disease in Emergency Mechanical Thrombectomy
CONCLUSION: The COVID-19 protection protocol significantly impacted the door-to-imaging time. Shortening the door-to-imaging time and performing the procedure under local anesthesia, if possible, may be required to reduce the door-to-puncture and doorto- recanalization times. The effect of various aspects of the protection protocol on emergency thrombectomy should be further studied.PMID:34879638 | DOI:10.3340/jkns.2021.0053
Source: Journal of Korean Neurosurgical Society - December 9, 2021 Category: Neurosurgery Authors: Jin Eun Min-Hyung Lee Sang-Hyuk Im Won-Il Joo Jae-Geun Ahn Do-Sung Yoo Hae-Kwan Park Source Type: research
Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports
CONCLUSIONS: Our study demonstrates that remdesivir, a novel drug applied to the treatment of COVID-19, does not have a significant association with adverse neurologic or psychiatric reactions in the real-world setting.PMID:34919240 | DOI:10.26355/eurrev_202112_27435
Source: Pharmacological Reviews - December 17, 2021 Category: Drugs & Pharmacology Authors: S Lee J W Yang S Y Jung M S Kim D K Yon S W Lee H-C Kang E Dragioti K Tizaoui L Jacob A Koyanagi J-E Salem K Kostev A Lascu J I Shin J H Kim L Smith Source Type: research
Abdominal aortic aneurysm ultrasound screening in men with risk factors in Primary Care
CONCLUSIONS: The prevalence of aneurysms in our sample was 2.6%, which was lower than expected. The wide use of ultrasound and its progressive generalisation in the Primary Care setting should lead to a decrease in the number of undiagnosed AAA.PMID:34920344 | DOI:10.1016/j.aprim.2021.102234
Source: Atencion Primaria - December 17, 2021 Category: Primary Care Authors: Jes ús Rodríguez Donoso Elena Mart ín Ramos Josefina Aparicio Velasco Leonardo Fonte Eliozondo Estrella Mu ñoz Críspulo Carmen Ruiz Arribas Source Type: research
Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports
CONCLUSIONS: Our study demonstrates that remdesivir, a novel drug applied to the treatment of COVID-19, does not have a significant association with adverse neurologic or psychiatric reactions in the real-world setting.PMID:34919240 | DOI:10.26355/eurrev_202112_27435
Source: European Review for Medical and Pharmacological Sciences - December 17, 2021 Category: Drugs & Pharmacology Authors: S Lee J W Yang S Y Jung M S Kim D K Yon S W Lee H-C Kang E Dragioti K Tizaoui L Jacob A Koyanagi J-E Salem K Kostev A Lascu J I Shin J H Kim L Smith Source Type: research
Abdominal aortic aneurysm ultrasound screening in men with risk factors in Primary Care
CONCLUSIONS: The prevalence of aneurysms in our sample was 2.6%, which was lower than expected. The wide use of ultrasound and its progressive generalisation in the Primary Care setting should lead to a decrease in the number of undiagnosed AAA.PMID:34920344 | DOI:10.1016/j.aprim.2021.102234
Source: Atherosclerosis - December 17, 2021 Category: Cardiology Authors: Jes ús Rodríguez Donoso Elena Mart ín Ramos Josefina Aparicio Velasco Leonardo Fonte Eliozondo Estrella Mu ñoz Críspulo Carmen Ruiz Arribas Source Type: research
Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports
CONCLUSIONS: Our study demonstrates that remdesivir, a novel drug applied to the treatment of COVID-19, does not have a significant association with adverse neurologic or psychiatric reactions in the real-world setting.PMID:34919240 | DOI:10.26355/eurrev_202112_27435
Source: Pharmacological Reviews - December 17, 2021 Category: Drugs & Pharmacology Authors: S Lee J W Yang S Y Jung M S Kim D K Yon S W Lee H-C Kang E Dragioti K Tizaoui L Jacob A Koyanagi J-E Salem K Kostev A Lascu J I Shin J H Kim L Smith Source Type: research
Abdominal aortic aneurysm ultrasound screening in men with risk factors in Primary Care
CONCLUSIONS: The prevalence of aneurysms in our sample was 2.6%, which was lower than expected. The wide use of ultrasound and its progressive generalisation in the Primary Care setting should lead to a decrease in the number of undiagnosed AAA.PMID:34920344 | DOI:10.1016/j.aprim.2021.102234
Source: Atencion Primaria - December 17, 2021 Category: Primary Care Authors: Jes ús Rodríguez Donoso Elena Mart ín Ramos Josefina Aparicio Velasco Leonardo Fonte Eliozondo Estrella Mu ñoz Críspulo Carmen Ruiz Arribas Source Type: research
Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports
CONCLUSIONS: Our study demonstrates that remdesivir, a novel drug applied to the treatment of COVID-19, does not have a significant association with adverse neurologic or psychiatric reactions in the real-world setting.PMID:34919240 | DOI:10.26355/eurrev_202112_27435
Source: European Review for Medical and Pharmacological Sciences - December 17, 2021 Category: Drugs & Pharmacology Authors: S Lee J W Yang S Y Jung M S Kim D K Yon S W Lee H-C Kang E Dragioti K Tizaoui L Jacob A Koyanagi J-E Salem K Kostev A Lascu J I Shin J H Kim L Smith Source Type: research
